Target Protein Interaction Profiling for TPD Development
* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.
Targeted protein degradation (TPD) is built on controlled protein-protein interactions. A degrader has to bind its protein of interest, recruit an E3 ubiquitin ligase, and hold the two proteins in an orientation that allows ubiquitin transfer. Whether that chain of events succeeds is decided long before a DC50 value is reported. BOC Sciences provides target protein interaction profiling services that map how degraders engage target proteins, E3 ligases, and the wider cellular interactome, so pharmaceutical and biotechnology teams can explain degradation efficiency, rule out unwanted interactions, and design better molecules with less trial and error. Our profiling connects biophysical binding analysis, cellular engagement assays, structural characterization, and proteomics-based interaction mapping, and it covers PROTACs, molecular glues, and emerging TPD modalities. When protein-level interactions are hard to predict from sequence alone, we also apply in silico protein-protein interactions prediction to guide the experimental plan.
Request a Consultation Explore ServicesServices
BOC Sciences Target Protein Interaction Profiling Services for TPD Development
Our profiling strategy is organized around the molecules involved in each interaction. We assess individual binding events, degrader-induced complexes, and broader cellular interaction networks. Assays and controls are selected according to the target protein, degrader mechanism, available material, and research question.
Target Protein-Degrader Interaction Profiling
We determine whether a degrader binds the intended target, how strongly it binds, and whether binding is maintained under relevant experimental conditions. The results establish the target-engagement component of a degradation mechanism.
- Binary binding affinity: Measure target-degrader interactions and estimate Kd using suitable binding affinity measurement methods.
- Binding kinetics and competition: Compare kon, koff, and ligand-competition behavior when the selected assay supports these measurements.
- Target engagement confirmation: Evaluate interactions in cellular systems and compare binding with observed target depletion.
E3 Ligase-Degrader Interaction Profiling
We examine degrader recruitment of E3 ligases or their substrate-recognition components. This service helps distinguish insufficient ligase engagement from downstream limitations in ubiquitination and degradation.
- E3 recruitment assessment: Characterize binding to VHL-, CRBN-, and other relevant E3-associated components.
- Ligase binding selectivity: Compare recruitment patterns across selected E3 systems when the degrader design permits.
- Mechanism-focused controls: Use competing ligands, inactive analogs, or appropriate protein controls to confirm interaction dependence.
Target Protein-Degrader-E3 Ligase Ternary Complex Profiling
For bifunctional degraders, binding to each protein does not guarantee a productive three-component assembly. We profile target-degrader-E3 interactions and connect complex behavior with subsequent ubiquitination and target degradation.
- Ternary complex formation: Use a tailored PROTAC ternary complex assay to assess assembly and concentration-dependent behavior.
- Cooperativity and stability: Evaluate whether target-E3 contacts favor complex formation and how long the complex persists.
- Productive recruitment: Compare complex readouts with ubiquitination, degradation potency, and potential hook effects.
Target Protein Interactome Profiling
We map proteins associated with a target in a defined biological system and investigate how the network changes after degrader treatment. This helps explain target function, protein-complex behavior, and unexpected degradation responses.
- Interaction partner discovery: Identify target-associated proteins by co-immunoprecipitation, affinity enrichment, and mass spectrometry.
- Stable and transient interactions: Apply proximity-based and time-resolved approaches when conventional enrichment misses short-lived associations.
- Interaction network comparison: Analyze treatment-dependent changes and validate priority partners while accounting for target abundance loss.
Which Protein Interactions Do You Need to Investigate?
Whether you need binary binding measurements, ternary complex analysis, or interactome mapping, BOC Sciences can tailor a profiling plan to your target and degrader.
TPD Modalities
Target Protein Interaction Profiling for Different TPD Modalities
Different degrader classes recruit different cellular partners. BOC Sciences selects interaction readouts that match the underlying mechanism instead of applying a PROTAC ternary complex assay to every modality.
Target Protein Interaction Analysis for PROTACs
PROTACs bring a target protein and an E3 ligase into proximity. We assess both binary interactions and the assembled target-PROTAC-E3 complex to identify why some designs degrade more efficiently than others.
- Target and E3 binding affinity and competition
- Ternary complex formation, cooperativity, and persistence
- Relationship between E3 recruitment, ubiquitination, and target degradation
Target Protein Interaction Analysis for Molecular Glue Degraders
Molecular glue degraders promote new or strengthened protein-protein interactions. Our profiling focuses on identifying recruited proteins and verifying the interactions responsible for degradation. These studies can complement molecular glue technology development.
- Degrader-induced E3-associated protein recruitment
- Neosubstrate discovery through interaction enrichment and proteomics
- Confirmation of recruitment, ubiquitination, and degradation relationships
Target Protein Interaction Analysis for LYTACs
LYTACs direct extracellular or cell-surface proteins toward lysosomal degradation by engaging trafficking receptors. We investigate target binding and receptor recruitment in appropriate cellular models, supporting LYTAC degradation technology development.
- Binding to the extracellular target and lysosomal trafficking receptor
- Receptor engagement involving CI-M6PR, ASGPR, or a suitable alternative
- Interaction-dependent internalization and lysosomal trafficking
Target Protein Interaction Analysis for AbTACs
Antibody-based degraders can link a cell-surface target to a membrane-associated E3 ligase. We evaluate simultaneous binding, membrane proximity, and the fate of the recruited target without assuming a conventional intracellular PROTAC mechanism.
- Bispecific binding to the surface target and membrane-associated E3 ligase
- Target-ligase proximity and receptor-dependent internalization
- Comparison of target depletion with lysosomal trafficking readouts
Target Protein Interaction Analysis for Autophagy-Targeting Degraders
Autophagy-directed strategies recruit targets to autophagic machinery through different recognition routes. We distinguish direct LC3-tethering approaches from adaptor-dependent recruitment and tailor assays to each design, including ATTEC degradation technology development.
- Target-LC3 interactions for autophagosome-tethering designs
- Target-p62/SQSTM1 association for relevant adaptor-dependent systems
- Cargo recruitment and autophagic delivery measured alongside target loss
Target Protein Interaction Analysis for Hydrophobic Tagging Degraders
Hydrophobic tags can expose a target to cellular protein-quality-control pathways. Rather than assuming direct recruitment of a fixed E3 ligase, we examine target association with relevant chaperones and degradation machinery.
- Target engagement by hydrophobic-tagged compounds
- Chaperone and quality-control partner association, including HSP70 where relevant
- Mechanism studies linking recognition to proteasomal target loss
Which Type of Degrader Are You Developing?
Tell us your degrader modality, target, and interaction challenge. BOC Sciences can select suitable assays and cellular models for your mechanism.
Value
Why Target Protein Interaction Profiling Matters for TPD Development?
Understanding Target Protein Functions and Interaction Networks
Target proteins rarely act in isolation. Profiling reveals the partners and complexes that define a target's biology, which is essential before deciding whether degradation is a sound strategy. Structural context from protein structure modeling often guides that decision.
Evaluating Productive Degrader-Induced Interactions
Not every degrader-induced interaction leads to degradation. Profiling separates productive complexes from non-productive or over-stabilized binding events, and methods such as molecular docking for protein-ligand analysis help visualize why one geometry works and another does not.
Explaining Degradation Efficiency and Resistance
Interaction data explain why two degraders with similar target affinity can differ widely in degradation potency. Dynamic interaction behavior captured by molecular dynamics simulation can reveal interaction-level causes of weak or lost degradation.
Identifying Off-Target Interactions and Selectivity Risks
Mapping interactions beyond the intended pair helps detect neo-substrate effects and selectivity liabilities early, when they are still inexpensive to fix. Dedicated PROTAC selectivity evaluation extends this into a structured risk profile.
Workflow
Our Target Protein Interaction Profiling Workflow
01
Project Consultation and Profiling Strategy Design
We start by understanding your target protein, degrader modality, intended E3 ligase, and the specific question you need answered. Together we define which interactions to profile and which techniques best fit your project stage.
02
Sample Preparation and Assay Setup
We prepare target proteins, ligase complexes, and degrader samples, then set up the appropriate biochemical or cellular assays. Protein quality and buffer conditions are optimized, drawing on custom protein expression & purification when a target is difficult to obtain.
03
Protein Interaction Detection and Validation
Interactions are measured with orthogonal techniques so results are cross-verified rather than resting on a single readout. This step captures binary binding, ternary complex formation, and cellular interaction behavior in parallel, supported by structural methods such as protein-ligand structure analysis and cryo-EM.
04
Data Analysis, Interpretation, and Reporting
We integrate affinity, kinetics, cooperativity, and selectivity data into a clear interaction map, then translate it into practical guidance for your next design cycle, including which interaction to strengthen, weaken, or avoid.
Which Profiling Stage Needs Support?
From assay planning and sample preparation to interaction validation and data interpretation, BOC Sciences can assist with the stage that fits your project.
Why Us
Why Choose BOC Sciences for Target Protein Interaction Profiling?
Comprehensive Interaction Profiling Capabilities Across TPD Modalities
We profile interactions for PROTACs, molecular glues, LYTACs, AbTACs, autophagy-targeting degraders, and hydrophobic tagging degraders, so one project can stay supported as its modality and mechanism evolve.
Integrated Biochemical, Cellular, and Proteomics Technologies
We combine biophysical binding, live-cell engagement, structural analysis, and proteomics, so interaction results are verified across systems instead of in isolation. Computational support such as virtual screening helps prioritize which interactions to test first.
Experienced Protein Biology and TPD Research Team
Our scientists work at the intersection of protein science and degrader pharmacology. We interpret interaction data in the context of degradation mechanism rather than reporting assay values alone, which makes the findings easier to act on.
Supporting TPD Research Products and Reagents
Beyond services, we provide supporting products and reagents, including molecular glue and ubiquitin ligase tools, that help clients run and cross-check their own interaction studies.
Applications
Applications of Target Protein Interaction Profiling in TPD Development
Target Degradability and Feasibility Assessment
Before committing to a degradation strategy, teams need to know whether a target can be degraded and whether a productive interaction with a chosen E3 ligase can be formed. Profiling provides the early evidence needed to judge feasibility, and complementary modeling such as 3D-QSAR can rank targets and ligands for follow-up.
Degrader Mechanism-of-Action Investigation
Interaction data show how a degrader works at the molecular level, including how it binds each partner, how the ternary complex assembles, and where the degradation pathway may be interrupted. Linking this to a degradation ability assay connects mechanism to measurable outcome.
Degradation Selectivity and Off-Target Interaction Assessment
By mapping interactions across the proteome, we help identify unintended partners and neo-substrate effects that may influence selectivity and downstream biology. Structured PROTAC off-target evaluation turns these findings into a clear liability picture.
Degrader Lead Optimization and Candidate Prioritization
Interaction profiles let teams compare candidates on more than potency alone. Differences in cooperativity, complex stability, and interaction selectivity guide optimization of the warhead, linker, and E3 ligand, with linker binding site selection and design helping to position the two proteins correctly.
Do You Have a Specific TPD Research Challenge?
If you need to assess target feasibility, explain a degradation mechanism, investigate selectivity, or compare lead compounds, BOC Sciences can build a focused interaction profiling strategy.
Case Study
Case Studies in Target Protein Interaction Profiling for TPD Development
Project Background
A Canadian biotechnology company was developing a VHL-recruiting PROTAC against BRD4 for epigenetic research, part of a broader interest in PROTACs targeting BET proteins. The lead compound degraded BRD4 efficiently, but a closely related analog with almost identical BRD4 affinity showed much weaker degradation. Standard degradation data could not explain the difference, so the client needed an interaction-level answer.
Technical Challenges
The two compounds differed only in linker length and exit vector, yet behaved very differently in cells. Binary binding data for both the BRD4 warhead and the VHL recruiter were nearly identical, which meant the source of the difference had to lie in how the two proteins came together rather than in how each end bound.
BOC Sciences Solutions
- Binary and Ternary Binding Comparison: We measured binary binding of each PROTAC to BRD4(BD2) and to the VHL complex, then measured ternary complex formation and calculated the cooperativity factor (α) for both compounds.
- Structure-Guided Interaction Analysis: We compared how each linker positioned the two proteins and where it placed the target relative to the ubiquitination machinery, identifying a geometric constraint in the weaker analog.
- Cellular Correlation: We paired the biophysical data with cellular degradation and target engagement assays to confirm that the interaction differences translated into measurable degradation differences.
Project Outcomes
The stronger degrader formed a ternary complex with clearly positive cooperativity, while the weaker analog showed near-neutral or negative cooperativity despite equivalent binary binding. The client used this interaction-level explanation to redesign the linker. In the follow-up series, a modified exit vector restored cooperativity and improved degradation potency while maintaining selectivity. Instead of trial and error, the team gained a rational basis for the next design round.
Project Background
A US-based research group was investigating a molecular glue that promotes Cyclin K degradation by inducing an interaction between CDK12 and DDB1, a component of the CUL4-RBX1-DDB1 E3 ligase complex.
Technical Challenges
Molecular glues stabilize a protein-protein interface rather than bridging two separate ligands, so standard binary binding assays were not informative. The client needed direct evidence that a new interaction between CDK12 and DDB1 was created, and needed to know how strong and how specific that interaction was. The project also overlapped with related PROTAC targeting CDK work in the same laboratory.
BOC Sciences Solutions
- Interaction Detection in Cells: We applied co-immunoprecipitation and mass spectrometry to detect and confirm the glue-induced CDK12-DDB1 interaction under native conditions.
- Interface and Complex Profiling: We profiled the induced interface and compared it with related complexes, using validated DDB1 reagents to anchor the assay.
- Selectivity Evaluation: We assessed the interaction across related proteins to define the glue's selectivity window and confirm that the effect was compound-dependent.
Project Outcomes
Profiling confirmed that the glue induced a productive CDK12-DDB1 interaction that was compound-dependent and absent in control cells. The interaction was specific to the intended complex and did not extend to closely related cyclin-dependent kinases. This evidence allowed the client to establish a clear mechanism of action and to prioritize analogs that preserved the induced interaction while reducing off-target binding.
Frequently Asked Questions (FAQ)
Why Does Strong Target Binding Not Guarantee Protein Degradation?
Strong binding affinity only indicates that a degrader can engage its target protein. Successful degradation also depends on additional molecular events. For PROTACs, these include E3 ligase recruitment, productive ternary complex formation, target ubiquitination, and subsequent proteasomal degradation. A compound may bind tightly to its target but form an unstable ternary complex or adopt an unfavorable geometry for ubiquitination. Limited cellular exposure can also reduce degradation efficiency. Target protein interaction profiling helps researchers evaluate binary binding, ternary complex formation, and cooperativity alongside cellular degradation results. This combined approach helps identify whether poor degradation arises from binding limitations, inefficient protein recruitment, or downstream mechanistic barriers, providing useful guidance for degrader optimization.
How Can Transient Degrader-Induced Protein Interactions Be Detected?
Transient or weak protein interactions can be difficult to capture because they may dissociate during cell lysis, protein extraction, or washing steps. Conventional co-immunoprecipitation may therefore miss certain interactions. Depending on the interaction duration and cellular context, researchers can use time-resolved proximity assays, proximity labeling, cross-linking approaches, or affinity purification coupled with mass spectrometry. These methods provide complementary information about protein recruitment and complex formation. However, protein proximity does not necessarily demonstrate direct physical binding. Negative controls, competition experiments, and independent validation methods are important for confirming meaningful interactions. Comparing results across experimental conditions helps distinguish genuine degrader-induced recruitment events from nonspecific background signals.
How Does Interactome Profiling Reveal Degrader Selectivity Risks?
Interactome profiling compares target-associated proteins and protein complex composition before and after degrader treatment. These comparisons help identify unexpected protein recruitment, altered interaction networks, and potential selectivity concerns. Affinity enrichment combined with quantitative mass spectrometry can reveal candidate interaction partners, while cellular protein abundance analysis helps determine whether associated proteins also change after treatment. Importantly, altered protein interactions do not necessarily indicate degradation, and reduced protein abundance does not independently establish direct binding. Time-course experiments, competition assays, inactive degrader controls, and orthogonal interaction measurements can help validate suspected off-target events. Integrating these results supports more informed selectivity assessment and helps prioritize follow-up investigations during degrader development.
Can BOC Sciences Customize Profiling for Different Degrader Types?
Yes. BOC Sciences designs target protein interaction profiling strategies according to the recruitment mechanisms and research objectives of different degrader modalities. For PROTACs, our services can examine target binding, E3 ligase engagement, and ternary complex formation. For molecular glue degraders, we focus on compound-induced protein recruitment and newly formed protein interactions. LYTAC and AbTAC studies may investigate cell surface target recognition, receptor or membrane-associated protein recruitment, and related trafficking events. Autophagy-targeting and hydrophobic tagging degraders require interaction assays suited to their protein recognition and quality control mechanisms. By selecting relevant biochemical, cellular, and proteomics approaches, we help researchers investigate the molecular interactions that influence degrader activity.
What Samples and Project Information Does BOC Sciences Need?
BOC Sciences begins by reviewing the target protein, degrader modality, available compound information, and the specific interaction questions the client wants to address. Details about the E3 ligase or recruited receptor, relevant cellular models, existing binding measurements, and degradation data help determine the most appropriate profiling strategy. Depending on the experimental design, required materials may include degrader compounds, recombinant proteins, cell lysates, or suitable cell models. Material requirements and controls are discussed during project planning. Our team can recommend suitable detection methods, establish interaction validation strategies, and integrate experimental findings into a structured interpretation. This approach helps clients connect protein interaction data with degrader mechanism studies and candidate optimization decisions.
Testimonials
Client Testimonials on Target Protein Interaction Profiling
Comprehensive Target Interaction Mapping
"Our target had a complex interaction network that we could not interpret from degradation data alone. BOC Sciences mapped the key interactions and showed us which ones actually mattered for degradation."
— Dr. Perry, Protein Science Lead at a German Biotechnology Company
Reliable Detection of Transient Protein Interactions
"Ternary complexes are transient and easy to miss. The team's orthogonal approach detected interactions our internal assays had overlooked and gave us data we could trust."
— Ms. Myers, Project Manager at an Italian Research Institute
Clear Insights into Degrader-Induced Complex Formation
"We had two degraders with nearly identical binding profiles but very different potency. The cooperativity analysis explained the gap and pointed us toward a better linker."
— Dr. Jenkins, Medicinal Chemistry Director at a UK-Based Pharmaceutical Company
Valuable Guidance for Degrader Candidate Selection
"The interaction profiling gave us a candidate ranking we could defend internally. We selected our lead degrader with far more confidence than before."
— Mr. Dubois, Discovery Program Manager at a French Biotech Firm
* PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
BOC Sciences Support
Please contact us with any specific requirements and we will get back to you as soon as possible.
